Percutaneous biliary metal wall stenting in malignant obstructive jaundice

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 8, 2003, Pages 915-919

  Indar, Adrian A ^a   Lobo, Dileep N ^a   Gilliam, Andrew D ^a   Gregson, Roger ^a   Davidson, Ian ^a   Whittaker, Simon ^a   Doran, John ^a   Rowlands, Brian J ^a   Beckingham, Ian J ^a,b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Biliary metal stents; Extrahepatic bile duct obstruction; Malignant jaundice; Percutaneous

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLBLADDER CANCER; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PANCREAS CARCINOMA; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

EID: 0042315313     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200308000-00013     Document Type: Article

References (12)

1. Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993; 25:207-212.
2. Lee MJ, Dawson SL, Mueller PR, Hahn PF, Saini S, Lu DS. Failed metallic biliary stents: causes and management of delayed complications. Clin Radiol 1994; 49:857-862.
3. Gillams A, Dick R, Dooley JS, Wallsten H, el-Din A. Self-expandable stainless steel braided endoprosthesis for biliary strictures. Radiology 1990; 174:137-140.
4. Lammer J, Hausegger KA, Fluckiger F, Winkelbauer FW, Wilding R, Klein GE, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 1996; 201:167-712.
5. Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; ii:57-62.
6. McLeod GG, Armstrong DN, Ross AH, Buist TA, Macleod IB. Management of malignant biliary obstruction by percutaneously introduced biliary endoprosthesis. J R Coll Surg Edinb 1986; 31:210-213.
7. Schmassmann A, von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996; 91:654-659.
8. Prat F, Chapat O, Ducot B, Ponchon T, Fritsch J, Chuory AD. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998; 42:76-80.
9. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219:325-331.
10. Puntis MC, Jiang WG. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J Gastroenterol Hepatol 1996; 11:7-13.
11. Dooley J. Extrahepatic biliary obstruction: systemic effects, diagnosis, management. In: Oxford Textbook of Clinical Hepatology. 2nd edition, vol. 2. Oxford: Oxford University Press; 1999. p. 1581.
12. Lee JG, Leung JW. Biliary stents - plastic or metal? Gastrointest Endosc 1998; 47:90-91.